Avoiding Weight Regain

You have lost weight.  GREAT JOB!   Now what?  Whether you used GLP-1 medication or not……you will always need to beware of weight re-gain.  So what is the evidence and what can we do to protect our new body weight and body composition?

The data suggests that for weight loss energy intake reduction is the strategy with greatest efficacy. This is not the case for weight loss maintenance.  To prevent weight re-gain exercise has the most evidence.

Body-Weight Set-point Theory

If you’ve been around the scale so to speak, then you may realize that your weight tends to fluctuate day to day around a certain body weight set point barring any major lifestyle, medication or circumstance change.  Weight is under biological control after all.  So when we use strategies and pharmaceuticals to implement a change and we are consistent over time we often see a change in our body weight set point.  Regulation of body weight is asymmetric, being more effective in response to weight loss than to weight gain.  This means it is much easier to gain weight than to lose weight!  But of course you probably knew that already!

Weight Regain and GLP-1 Medications

GLP-1 medicines—such as semaglutide (Ozempic, Wegovy), liraglutide (Saxenda), and tirzepatide (Mounjaro, Zepbound)—can help people lose weight by reducing appetite and increasing fullness.

When treatment is stopped, some weight regain is common. In one semaglutide study, people regained about two-thirds of the weight they had lost within a year after stopping treatment. Similar findings have been reported after stopping tirzepatide.

What does this mean?  YOU NEED A PLAN

  • Regaining weight does not mean the medicine failed or that the person lacked willpower.
  • The body often responds to weight loss by increasing hunger and reducing energy expenditure. GLP-1 medicines help counter some of these biological changes while they are being taken. This is called metabolic adaptation. 
  • People do not necessarily regain all of the weight they lost. The amount varies from person to person.
  • Some improvements in blood sugar, blood pressure, cholesterol, and other health measures may also lessen if substantial weight is regained.

Maintaining results?  IT IS POSSIBLE

Absolutely! However, keeping the weight off requires a permanent strategy. This includes a combination of sustained nutritional habits, consistent physical activity, quality sleep, stress mitigation, and professional follow-up. Current medical consensus suggests we should view weight management as chronic care, rather than assuming a temporary intervention will lead to a lifelong fix.

Key Components for Maintenance Success

  1. Monitoring Caloric Intake: We manage what we track. Following a loss, the body often triggers a biological drive to consume more while burning less. Staying mindful of your intake serves as a vital safeguard against drifting back to a previous set point.
  2. Consistent Weigh-ins: Stepping on the scale weekly or daily provides valuable feedback. To minimize frustration from natural daily shifts, consider looking at your weekly average to keep an eye on the overall trend.
  3. Boosting Energy Output: While diet is key for losing weight, exercise has the most evidence for preventing regain. Sticking with your movement routine is essential even after reaching your target weight.
  4. Strategic Tapering of Medication: Stopping GLP-1 medicines abruptly can lead to rebound hunger. A slow, supervised weaning process is highly recommended to improve your chances of long-term success.
  5. Optimizing Health Fundamentals: True sustainability involves addressing the root drivers of weight. This means focusing on gut health, hormone balance, metabolic function, toxic load, and restorative sleep for lasting results.

References:

Berg S, Stickle H, Rose SJ, Nemec EC. Discontinuing glucagon-like peptide-1 receptor agonists and body habitus: A systematic review and meta-analysis. Obes Rev. 2025 Aug;26(8):e13929. doi: 10.1111/obr.13929. Epub 2025 Apr 4. PMID: 40186344.

Horn DB, Linetzky B, Davies MJ, Laffin LJ, Wang H, Murphy MA, Zimner-Rapuch S, Lau E, Arad AD, Lee CJ. Cardiometabolic Parameter Change by Weight Regain on Tirzepatide Withdrawal in Adults With Obesity: A Post Hoc Analysis of the SURMOUNT-4 Trial. JAMA Intern Med. 2026 Feb 1;186(2):157-167. doi: 10.1001/jamainternmed.2025.6112. PMID: 41284285; PMCID: PMC12645400

Comments are closed.